EUVIMEDEUVIMED entdecken
CrossrefInfokarte

AIM2 Promotes Neuronal Apoptosis Through NF-κB Activation in an OxyHb-Induced In Vitro Subarachnoid Hemorrhage

Hailong Ji, Tianming Mao, Yuan Chen, Zimo Jin, Tian Yan, Hanghuang Jin

Journal of Integrative Neuroscience · 2026-10-13 · 25 (10)

DOI: 10.31083/jin50383 ↗
AbstractBibliografische Angaben

Abstract

Background: Subarachnoid hemorrhage (SAH) induces early brain injury (EBI) characterized by neuronal apoptosis, inflammation, and neurological dysfunction, yet the underlying mechanisms remain incompletely understood. Although absent in melanoma 2 (AIM2) has been implicated in post-SAH pathology, its role in neuronal injury remains unclear. Methods: Transcriptomic analyses of Gene Expression Omnibus (GEO) datasets (GSE36791 and GSE73378) were performed to investigate the association between AIM2 and nuclear factor κB (NF-κB)-related signaling. An oxyhemoglobin (OxyHb)-induced in vitro SAH model, Aim2 knockdown, and Rela co-silencing experiments were used to evaluate neuronal apoptosis, viability, and NF-κB activation. In vivo validation was performed in SAH brain tissues. Results: Transcriptomic analyses showed a positive association between AIM2 expression and NF-κB signaling. In OxyHb-treated neurons, AIM2 expression and p65 phosphorylation were increased, accompanied by enhanced neuronal apoptosis and reduced viability. Aim2 knockdown attenuated NF-κB activation, reduced neuronal apoptosis, and improved cell viability, whereas co-silencing of Aim2 and Rela exerted stronger neuroprotective effects. Aim2 silencing showed limited effects on pyroptosis-related responses, and in vivo analyses further supported a positive association between AIM2 expression and NF-κB activation after SAH. Conclusions: AIM2 contributes to OxyHb-induced neuronal apoptosis, at least in part, through NF-κB signaling. These findings provide new insight into the molecular mechanisms underlying EBI after SAH.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →